Trial Profile
PROMISE AMI (PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in Acute Myocardial Infarction treated by primary PCI) Pilot Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2014
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms PROMISE AMI
- 02 Jul 2014 New trial record